Medable launched its Agentic Accelerator Program to help life sciences sponsors deploy agentic AI across clinical development workflows. The program includes onboarding, integration support, governance, and change management led by clinical development AI experts and forward-deployed engineers. The company said the offering addresses a gap where only 22% of life sciences leaders have scaled AI across enterprises, with fewer transforming clinical development. Medable’s Agent Studio platform combines no-code agent creation, human-in-the-loop oversight, and GxP-ready compliance controls. CEO Michelle Longmire said customers want faster time to value while protecting proprietary agentic clinical development strategies, positioning governance as a core product requirement rather than an afterthought.